Dr. Reddy's Laboratories Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1171Market Cap
₹ 96,852 Cr.Stock P/E
30.1ROE
11.2 %RSI
46.19Trend
BearishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Dr Reddys Laboratories Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Dr Reddys Laboratories Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Dr Reddys Laboratories Ltd share price chart currently indicates a Bearish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1171 |
| RSI (14) | 46.19 |
| 50 DMA | 1223.75 |
| 200 DMA | 1256.08 |
| Trend | Bearish |
| A/D Rating | E |
| RS Rating | 19 |
| EPS Rating | 9 |
| TI65 | 0.95 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Dr. Reddy's Laboratories Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1191.84 |
| R2 | ₹1185.87 |
| R1 | ₹1178.44 |
| PP | ₹1172.47 |
| S1 | ₹1165.04 |
| S2 | ₹1159.07 |
| S3 | ₹1151.64 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 96,852 Cr. |
| Current Price | ₹ 1,171 |
| High / Low | ₹ 1,415 / 1,080 |
| Stock P/E | 30.1 |
| Book Value | ₹ 454 |
| Dividend Yield | 0.68 % |
| ROCE | 13.0 % |
| ROE | 11.2 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2023 | 6,758 | 1,405 | 31% |
| Sep 2023 | 6,903 | 1,482 | 29% |
| Dec 2023 | 7,237 | 1,381 | 28% |
| Mar 2024 | 7,114 | 1,310 | 26% |
| Jun 2024 | 7,696 | 1,392 | 28% |
| Sep 2024 | 8,038 | 1,342 | 26% |
| Dec 2024 | 8,381 | 1,404 | 27% |
| Mar 2025 | 8,528 | 1,587 | 23% |
| Jun 2025 | 8,572 | 1,410 | 25% |
| Sep 2025 | 8,828 | 1,337 | 23% |
| Dec 2025 | 8,753 | 1,190 | 22% |
| Mar 2026 | 7,546 | 221 | 5% |
| Jun 2026 | 8,100 | 436 | 11% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 26.79% |
| FIIs | 32.40% |
| DIIs | 10.55% |
| Public | 30.26% |
| Others | 0.00% |
| No. of Shareholders | 1,29,501 |
Pros and Cons
Pros
Cons
- Primary trend direction remains weak, stuck underneath major defensive supply barriers.
Related NSE Stocks
United Breweries Ltd.
View Share Price Analysis →Hindalco Industries Ltd.
View Share Price Analysis →Bharat Petroleum Corporation Ltd.
View Share Price Analysis →Birlasoft Ltd.
View Share Price Analysis →Jupiter Wagons Ltd.
View Share Price Analysis →Tata Elxsi Ltd.
View Share Price Analysis →Premier Energies Ltd.
View Share Price Analysis →Mangalore Refinery & Petrochemicals Ltd.
View Share Price Analysis →HCL Technologies Ltd.
View Share Price Analysis →Aditya Birla Fashion and Retail Ltd.
View Share Price Analysis →Chalet Hotels Ltd.
View Share Price Analysis →Jubilant Foodworks Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Dr Reddys Laboratories Ltd share?
Based on the latest closing data, the technical momentum for Dr Reddys Laboratories Ltd is currently evaluated as Bearish. The stock is exhibiting an RSI (14) of 46.19, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1223.75) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Dr Reddys Laboratories Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Dr Reddys Laboratories Ltd today centers at a Pivot Point (PP) of ₹1172.47. Upside resistance challenges are calculated at R1: ₹1178.44, R2: ₹1185.87, and R3: ₹1191.84. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1165.04, S2: ₹1159.07, and S3: ₹1151.64.
How does the fundamental ROE and P/E ratio look for Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd is currently trading with a valuation metrics context of a Stock P/E of 30.1, against a core structural efficiency Return on Equity (ROE) standing at 11.2 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 9, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Dr Reddys Laboratories Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Structural Downward Distribution Phase (Avoid / Sell Setup). Dr Reddys Laborator... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of E, a Relative Strength (RS) ranking of 19, and long-term trend backing from the TI65 indicator (Neutral pattern).